Two-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study.

Luchetti Gentiloni MM, Foti R, Selmi C, Cipollone F, Iannone F, Dagna L, Idolazzi L, Chimenti MS, Gentileschi S, Ramonda R, Ciccia F, Zabotti A, Lubrano E, Caporali R, D'Agostino MA, Scarlini A, Ippati S, Giurdanella F, Avitabile A

Open source

DOI
10.1007/s40744-026-00890-x
Published
2026 Nov 10
Container
Rheumatology and therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40744-026-00890-x,
  title = {Two-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study.},
  author = {Luchetti Gentiloni MM and Foti R and Selmi C and Cipollone F and Iannone F and Dagna L and Idolazzi L and Chimenti MS and Gentileschi S and Ramonda R and Ciccia F and Zabotti A and Lubrano E and Caporali R and D'Agostino MA and Scarlini A and Ippati S and Giurdanella F and Avitabile A},
  year = {2026},
  journal = {Rheumatology and therapy},
  doi = {10.1007/s40744-026-00890-x},
  url = {https://doi.org/10.1007/s40744-026-00890-x}
}

RIS

TY  - JOUR
TI  - Two-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study.
AU  - Luchetti Gentiloni MM
AU  - Foti R
AU  - Selmi C
AU  - Cipollone F
AU  - Iannone F
AU  - Dagna L
AU  - Idolazzi L
AU  - Chimenti MS
AU  - Gentileschi S
AU  - Ramonda R
AU  - Ciccia F
AU  - Zabotti A
AU  - Lubrano E
AU  - Caporali R
AU  - D'Agostino MA
AU  - Scarlini A
AU  - Ippati S
AU  - Giurdanella F
AU  - Avitabile A
PY  - 2026
JO  - Rheumatology and therapy
DO  - 10.1007/s40744-026-00890-x
UR  - https://doi.org/10.1007/s40744-026-00890-x
ER  - 

APA

MM, L. G., R, F., C, S., F, C., F, I., L, D., L, I., MS, C., S, G., R, R., F, C., A, Z., E, L., R, C., MA, D., A, S., S, I., F, G., & A, A. (2026). Two-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study.. Rheumatology and therapy. https://doi.org/10.1007/s40744-026-00890-x

Source records